HEALTH | Page 8 | Center on Addiction


Five Minutes With Stephen Ross, MD, Expert in the Therapeutic Application of Psychedelic Drugs

As part of Center on Addiction Speaker Series, in which leading experts present their latest findings, Stephen Ross, MD, Associate Professor and Director of Addiction Psychiatry at NYU Medical Center, discussed his latest findings on using psilocybin to reduce the psychological effects and severe stress that many advanced stage cancer patients face. We spoke with Dr. Ross to hear a little bit more about this fascinating area of research.

Have The Talk with Your Kids in the New Year

A new year calls for new beginnings and new conversations. Some of the more difficult conversations are the ones that parents have with their children pertaining to alcohol and drug use. Nevertheless, they are important talks to have. Research tells us that teens who are educated about the risks of drugs from their parents are less likely to use. In fact, most teens credit conversations with Mom and Dad as their main reason for deciding not to do drugs. 

Drinking During the Holiday Season: What to be Aware of

It’s the most wonderful time of the year – spending quality time with family and friends, gift giving and receiving, and holiday parties. With this merriment often comes more drinking, but what is it about these parties that makes people drink more than they usually do? It turns out your holiday celebrations can impact your alcohol consumption in ways you may not expect.

There’s No Medical Justification to Limit Access to Life-Saving Opioid Treatment Buprenorphine

There is a long standing federal policy in the U.S. limiting access to life-saving treatments for people addicted to opioids. One of the most effective treatments for opioid addiction – buprenorphine – can only be prescribed by doctors who have completed a special training and qualify for a Drug Enforcement Agency (DEA) waiver. Doctors who get the waiver can then treat up to 30 patients in their first year and up to 100 patients in subsequent years.  

A Day in the Life of a Research Associate at CASAColumbia

An important part of the work being done at CASAColumbia is the research that helps to inform and guide the public, evaluate and improve health care, and analyze and recommend policies on substance use and addiction. But what exactly does that mean and what type of research is being conducted? We sat down with Alma Hidalgo, M.A., Research Associate to find out a little bit more about the exciting work she does at CASAColumbia and how it impacts the community.  

A different “magic” from magic mushrooms? Mystical experiences ease end-of-life distress

Research exploring the medicinal value of psychedelic drugs like LSD (commonly known as “acid”) and psilocybin (a natural compound found in “magic” mushrooms) is making a comeback and the results are encouraging. Several new studies indicate that small doses of psychedelic drugs, administered under the supervision of medical and mental health professionals, can effectively treat some psychological conditions, including end-of-life distress in patients with terminal cancer. 

Newsletter Additional Information

Newsletter Additional Information

Thank you for subscribing

This information will be used to better customize your experience and help inform future tools and features on our website.

Additional Information
What brought you to our website?